UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Projection Space Implementation of Deep Learning-Guided Low-Dose Brain PET Imaging Improves Performance over Implementation in Image Space

Journal of Nuclear Medicine, 2020-09, Vol.61 (9), p.1388-1396

2020

Volltextzugriff (PDF)

EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0

European journal of nuclear medicine and molecular imaging, 2020-07, Vol.47 (8), p.1885-1912

2020

Volltextzugriff (PDF)

Deep learning‐guided joint attenuation and scatter correction in multitracer neuroimaging studies

Human brain mapping, 2020-09, Vol.41 (13), p.3667-3679

2020

Volltextzugriff (PDF)

Gender differences in healthy aging and Alzheimer's Dementia: A 18F‐FDG‐PET study of brain and cognitive reserve

Human brain mapping, 2017-08, Vol.38 (8), p.4212-4227

2017

Volltextzugriff (PDF)

EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3

European journal of nuclear medicine and molecular imaging, 2022-01, Vol.49 (2), p.632-651

2022

Volltextzugriff (PDF)

Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2110-2120

2021

Volltextzugriff (PDF)

2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS

European journal of nuclear medicine and molecular imaging, 2022-02, Vol.49 (3), p.1090-1091

2022

Volltextzugriff (PDF)

Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Neurobiology of aging, 2017-04, Vol.52, p.183-195

2017

Volltextzugriff (PDF)

Molecular imaging and fluid biomarkers of Alzheimer’s disease neuropathology: an opportunity for integrated diagnostics

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2067-2069

2021

Volltextzugriff (PDF)

[18F]FDOPA positron emission tomography for cardiac innervation imaging: a new way or a dead-end street?

Clinical autonomic research, 2022-12, Vol.32 (6), p.399-401

2022

Volltextzugriff (PDF)

Highlights of the 32th Annual Congress of the EANM, Barcelona 2019: the nucleolympic games of nuclear medicine—a global competition for excellence

European journal of nuclear medicine and molecular imaging, 2020-07, Vol.47 (8), p.1808-1819

2020

Volltextzugriff (PDF)

A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET

European journal of nuclear medicine and molecular imaging, 2022-01, Vol.49 (2), p.563-584

2022

Volltextzugriff (PDF)

Distinctive clinical and imaging trajectories in SWEDD and Parkinson’s disease patients

NeuroImage clinical, 2024-01, Vol.42, p.103592-103592, Article 103592

2024

Volltextzugriff (PDF)

In Vivo TSPO Signal and Neuroinflammation in Alzheimer's Disease

Cells (Basel, Switzerland), 2020-08, Vol.9 (9), p.1941

2020

Volltextzugriff (PDF)

Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Neurobiology of aging, 2017-04, Vol.52, p.214-227

2017

Volltextzugriff (PDF)

Clinical Nuclear Medicine in Neurology: An Atlas of Challenging Cases

1st ed. 2022., 2021

Volltextzugriff (PDF)

Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer’s Disease

Current Alzheimer research, 2020-01, Vol.17 (2), p.112-125

2020

Volltextzugriff (PDF)

Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2200-2211

2021

Volltextzugriff (PDF)

The role of molecular imaging in assessing degenerative parkinsonism – an updated review

Swiss medical weekly, 2018-04, Vol.148 (1718)

2018

Volltextzugriff (PDF)

Preserved Extrastriatal 123I-FP-CIT Binding in Scans Without Evidence of Dopaminergic Deficit (SWEDD)

Molecular imaging and biology, 2020-12, Vol.22 (6), p.1592-1599

2020

Volltextzugriff (PDF)

Feeling of presence in dementia with Lewy bodies is related to reduced left frontoparietal metabolism

Brain imaging and behavior, 2020-08, Vol.14 (4), p.1199-1207

2020

Volltextzugriff (PDF)

Gender issues in the nuclear medicine community: results from a survey promoted by the EANM Women Empowerment Task Force

European journal of nuclear medicine and molecular imaging, 2022-06, Vol.49 (7), p.2106-2112

2022

Volltextzugriff (PDF)

Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2157-2168

2021

Volltextzugriff (PDF)

Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2086-2096

2021

Volltextzugriff (PDF)

The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (7), p.2070-2085

2021

Volltextzugriff (PDF)

1 – 25 von 443

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(363)
Mit Volltextzugriff
(381)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(215)
Life Sciences & Biomedicine
(212)
Humans
(138)
Neurosciences & Neurology
(108)
Alzheimer's Disease
(81)
Medicine
(79)
Radiology, Nuclear Medicine & Medical Imaging
(76)
Medicine & Public Health
(74)
Neurosciences
(70)
Female
(69)
Nuclear Medicine
(69)
Male
(68)
Positron Emission Tomography
(67)
Imaging
(66)
Clinical Neurology
(65)
Radiology
(63)
Oncology
(61)
Dementia
(57)
Middle Aged
(57)
Aged
(55)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Projection Space Implementation of Deep Learning-Guided Low-Dose Brain PET Imaging Improves Performance over Implementation in Image Space

EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0

Deep learning‐guided joint attenuation and scatter correction in multitracer neuroimaging studies

Gender differences in healthy aging and Alzheimer's Dementia: A 18F‐FDG‐PET study of brain and cognitive reserve

EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3

Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

2-[18F]FDG-PET/CT for early response and brain metabolic pattern assessment after CAR-T cell therapy in a diffuse large B cell lymphoma patient with ICANS

Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Molecular imaging and fluid biomarkers of Alzheimer’s disease neuropathology: an opportunity for integrated diagnostics

[18F]FDOPA positron emission tomography for cardiac innervation imaging: a new way or a dead-end street?

Highlights of the 32th Annual Congress of the EANM, Barcelona 2019: the nucleolympic games of nuclear medicine—a global competition for excellence

A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET

Distinctive clinical and imaging trajectories in SWEDD and Parkinson’s disease patients

In Vivo TSPO Signal and Neuroinflammation in Alzheimer's Disease

Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Clinical Nuclear Medicine in Neurology: An Atlas of Challenging Cases

Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer’s Disease

Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison

The role of molecular imaging in assessing degenerative parkinsonism – an updated review

Preserved Extrastriatal 123I-FP-CIT Binding in Scans Without Evidence of Dopaminergic Deficit (SWEDD)

Feeling of presence in dementia with Lewy bodies is related to reduced left frontoparietal metabolism

Gender issues in the nuclear medicine community: results from a survey promoted by the EANM Women Empowerment Task Force

Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives

Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework

The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update

Suchergebnisse filtern